In general, gene variants start out with > 99% the original variant and < 1% the new variant. So at some point, most people were probably OO, and a baby was born with mutant AO genotype. Then A spreads from the mutant.
For modeling purposes, I'll start with 50000 people, set the generation span at 20 years, and on average, each female will have 2.004 surviving children. Well, then the mutant population grows at the same rate as the general population, so remains at a tiny fraction.
So I update the model to provide a tiny advantage to the mutant by giving the mutant phenotype more surviving children per generation.
If I set up the model to start with 49998 OO, 1 AO, and 1 BO, set type O reproductive success at 2.004, type A at 2.013, type B at 2.012, and type AB at 2.013, and let it go for 2500 generations (50k years), the ending population is about 20M total, 41% O, 42% A, 11% B, and 4% AB.
That amounts to a relative advantage of only 0.45%. Obviously, the A and B mutations are very unlikely to have occurred at the same time, but it looks like both may have occurred after humans had already migrated from Asia to North and South America, as natives of South America are almost entirely type-O, and the presence of type A in North America may be explainable by Clovis migrants from Europe. So a 50ky timespan is actually a bit too long.
It seems as though there must be a selective advantage to A and B antigens, or that they be linked with an advantage, otherwise, they would not be observable as a significant population now.
[Edit:] Note that this only applies to pre-medicine. Blood type compatibility for the purposes of transfusions is definitely a survival advantage now. If current technology and politics were fixed for the next 50ky, it is likely that the "O" gene variant would become rare, and AA, BB, and AB genotypes would dominate.